This is unpublished
News

FDA Lifts Ban on Sending Mifepristone by Mail

January 27, 2022
Pinned
Back to top

Dr. Emily Godfrey, Associate Professor of ObGyn, was recently quoted in a Prevention article about the recent FDA decision to lift its existing ban on sending Mifepristone in the mail. Dr. Godfrey stated “Mifepristone is a really important medication not only for people who are seeking pregnancy termination, but also for people who are seeking miscarriage management.”. Read the article at this link.

News Categories

Recent News

1 week ago
Dr. Kemi Doll interviewed in New York Times article about ut…
doll
2 weeks 5 days ago
Study on anogenital cancers in individuals with Fanconi Anem…
Arial view of fountain and college campus
1 month 3 weeks ago
UW Departments of Obstetrics & Gynecology and Family Med…